Immunology & Oncology

Immunology & Oncology April 6, 2023

How ChAT+ T Cells are Revolutionizing Our Understanding of Blood Flow and Inflammation!

The recent study by Karolinska Institutet sheds new light on the regulation of blood flow and inflammation by acetylcholine.

Immunology & Oncology March 23, 2023

TransCure bioServices: A New Way to Study AML

In hopes of advancing acute myeloid leukemia (AML) preclinical investigations, TransCure bioServices provides cell line-derived xenograft (CDX) mice models.

Immunology & Oncology March 22, 2023

Creativity at Its Finest: Creative Proteomics’ Cytokine Assay Bags a Win for Immuno-Oncology

Creative Proteomics launches Cancer Cytokines Assay, which can identify multiple cytokine levels in a single sample.

Immunology & Oncology March 10, 2023

Understanding the Cellular Basis of Immunity

The simplest definition of the human immune system can be found in the cells that compose it.

Immunology & Oncology February 15, 2023

Targeting Cancer with Tech and Therapeutics: An MD Anderson-Xilis Collaboration

Under a preclinical joint research, MD Anderson’s capabilities in oncology research and pharmaceutical innovation is combined with Xilis’ MicroOrganoSphere™ technology.

Immunology & Oncology February 13, 2023

Vanquishing Menacing Malignancies, A Never-Ending Takeda Commitment

With decades of leadership in cancer therapeutics and having a diverse and robust pipeline, Takeda Oncology stays true to its commitment of bringing Better Health and a Brighter Future to people worldwide.

Immunology & Oncology January 13, 2023

What Surgery Can’t Finish, CAR T Might

After breast cancer surgery, preclinical research leads up clinical trials for CAR T cell therapy.

Immunology & Oncology December 20, 2022

Myokine Up, Tumor Down: Exercise vs Cancer

High-intensity interval training by advanced prostate cancer patients effects an acute exercise-induced myokine response and a decrease of tumor development in their serum.

Immunology & Oncology November 28, 2022

Counterintuitive Rheology Sheds Light to Novel Cancer Mechanobiology

Research Teams of JHU’s Konstantopoulos and UPF’s Valverde collaborate to shed light on counterintuitive rheology of cancer cells.

Immunology & Oncology November 25, 2022

Tinkering with Tankyrase Ushers a New Era of Pharmacologics

Inner workings of tankyrase uncovered by researchers, opening the door for possibly better and less harmful cancer treatments.

Immunology & Oncology October 29, 2022

Overcoming Immune Checkpoint Inhibitor Resistance

Overcoming treatment resistance to Immune Checkpoint Inhibitors remains a crucial concern as the modality matures in the mainstream

Immunology & Oncology October 29, 2022

Oncomirs: miRNA and Cancer

We explore the potential of miRNA as a cancer biomarker and its potential for future tumour diagnostics in oncology.

Immunology & Oncology October 27, 2022

Natural Killers in Oncology

Natural Killers emerge as an avenue of delivering immunotherapies; we outline their inherent strengths and limitations that must be overcome.

Featured June 28, 2022

Shining a Light on Cancer: Phototherapy

Photodynamic therapy presents opportunities to innovate on cancer treatments – we examine how through a brief history

Immunology & Oncology April 28, 2022

Recent Developments in Pancreatic Cancer

Pancreatic cancer is the most lethal cancer. New research promises to improve prognoses with innovations in treatment and diagnostics.

Immunology & Oncology April 21, 2022

Cancer & Mental Health: An Underserved Intersection

Cancer and Mental Health are closely intertwined. Exploring the interface between the two areas is critical in the fight against cancer.

Immunology & Oncology March 23, 2022

Smelling Cancer: Non-invasive Detection

Volatile organic compounds hold promise as predictors and biomarkers for cancer – animals can smell them, and eNoses can be made to do so too

Immunology & Oncology February 23, 2022

The Long Game: Targeting KRAS

KRAS, the first oncogene to be discovered, has led to many novel understandings – but therapies targeting it directly remain in short supply

Immunology & Oncology February 17, 2022

Infecting the Tumor: Oncolytic Viruses

The potential for oncolytic viruses to provide breakthroughs has long been recognized – but work has only recently begun in earnest

Immunology & Oncology January 26, 2022

The Microbiome in Cancer

The microbiome has gained increasing traction for its role across a spectrum of health conditions – we examine its significance in cancer.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings

Blueprint of Hope: The Evolution of 3D Printing in Renal Transplantation

Redefining Clinical Excellence in Spinal Care Through AI: The Rise of Machine Learning in Diagnosis and Prognosis

Data Deluge in Modern Healthcare: Navigating the Big Data Ocean